Literature DB >> 19912688

[Identification of metastasis-related microRNAs of hepatocellular carcinoma in hepatocellular carcinoma cell lines by quantitative real time PCR].

Yue Zhao1, Hu-liang Jia, Hai-jun Zhou, Qiong-zhu Dong, Li-yun Fu, Zhao-wei Yan, Jian Sun, Ning Ren, Qing-hai Ye, Lun-xiu Qin.   

Abstract

OBJECTIVE: To identify the metastasis-related miRNAs in hepatocellular carcinoma (HCC) cell lines.
METHODS: A qRT-PCR method was established and optimized.
RESULTS: All candidate metastasis associated miRNAs except miR-124a were expressed in high metastasis cell line MHCC97H and low metastasis cell line MHCC97L, while some miRNAs were differentially expressed between liver cancer cell line (HepG2) and hepatic cell line (L02) (P less than 0.05), these miRNAs include: miR-148b (1.96+/-0.51 vs 3.76+/-0.28), miR-9 (-4.38+/-0.86 vs -1.10+/-0.53), miR-30c (8.41+/-0.40 vs 6.82+/-0.29), miR-338 (3.14+/-0.29 vs -2.36+/-0.32), miR-34a (0.71+/-0.40 vs -2.95+/-0.26), Let-7g (-4.07+/-0.55 vs -6.98+/-0.56). miR-148b expression was about 4 times higher than miR-148a [5.46 (IQR 4.25-6.67) vs 1.29 (IQR 0.94-1.64)] in all cell line tested (Z=-5.097, P=3x10(-7)).
CONCLUSION: This study may help to understand the biological significance of miRNAs in HCC metastasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19912688

Source DB:  PubMed          Journal:  Zhonghua Gan Zang Bing Za Zhi        ISSN: 1007-3418


  13 in total

1.  Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening.

Authors:  Jin-shan Yang; Bao-jian Li; Hua-wei Lu; Yu Chen; Chuan Lu; Rui-xia Zhu; Si-hai Liu; Qing-ting Yi; Jing Li; Chun-hui Song
Journal:  Tumour Biol       Date:  2014-12-14

2.  MicroRNA-148b expression is decreased in hepatocellular carcinoma and associated with prognosis.

Authors:  Zhiyong Zhang; Wei Zheng; Jun Hai
Journal:  Med Oncol       Date:  2014-05-08       Impact factor: 3.064

3.  miRNAs in newt lens regeneration: specific control of proliferation and evidence for miRNA networking.

Authors:  Kenta Nakamura; Nobuyasu Maki; Albert Trinh; Heidi W Trask; Jiang Gui; Craig R Tomlinson; Panagiotis A Tsonis
Journal:  PLoS One       Date:  2010-08-11       Impact factor: 3.240

4.  MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation.

Authors:  Yong-Xi Song; Zhen-Yu Yue; Zhen-Ning Wang; Ying-Ying Xu; Yang Luo; Hui-Mian Xu; Xue Zhang; Li Jiang; Cheng-Zhong Xing; Yong Zhang
Journal:  Mol Cancer       Date:  2011-01-04       Impact factor: 27.401

5.  The evolutionary pattern and the regulation of stearoyl-CoA desaturase genes.

Authors:  Xiaoyun Wu; Xiaoju Zou; Qing Chang; Yuru Zhang; Yunhai Li; Linqiang Zhang; Jingfei Huang; Bin Liang
Journal:  Biomed Res Int       Date:  2013-11-07       Impact factor: 3.411

Review 6.  Role of MicroRNAs in Hepatocellular Carcinoma.

Authors:  Zixiang Zhu; Xiangle Zhang; Guoqing Wang; Haixue Zheng
Journal:  Hepat Mon       Date:  2014-08-01       Impact factor: 0.660

Review 7.  Genomics, microRNA, epigenetics, and proteomics for future diagnosis, treatment and monitoring response in upper GI cancers.

Authors:  Björn L D M Brücher; Yan Li; Philipp Schnabel; Martin Daumer; Timothy J Wallace; Rainer Kube; Bruno Zilberstein; Scott Steele; Jan L A Voskuil; Ijaz S Jamall
Journal:  Clin Transl Med       Date:  2016-04-06

Review 8.  The microRNA-148/152 family: multi-faceted players.

Authors:  Yue Chen; Yong-Xi Song; Zhen-Ning Wang
Journal:  Mol Cancer       Date:  2013-05-19       Impact factor: 27.401

9.  Reexpression of Let-7g microRNA inhibits the proliferation and migration via K-Ras/HMGA2/snail axis in hepatocellular carcinoma.

Authors:  Ke-Ji Chen; Ying Hou; Kui Wang; Jun Li; Yong Xia; Xiao-Yu Yang; Gang Lv; Xiang-Lei Xing; Feng Shen
Journal:  Biomed Res Int       Date:  2014-03-04       Impact factor: 3.411

10.  miR-148b-3p inhibits malignant biological behaviors of human glioma cells induced by high HOTAIR expression.

Authors:  Guan Wang; Zhaohui Li; Nan Tian; Liang Han; Yao Fu; Zhigang Guo; Yu Tian
Journal:  Oncol Lett       Date:  2016-06-16       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.